Abstract
CLL-586 Real-World Dosing Patterns and Outcomes Among Patients With Chronic Lymphocytic Leukemia With or Without Dose Adjustment of First-Line Ibrutinib
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have